SSCART-19 clinical trials
Also written ssCART-19.
How each study uses SSCART-19 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the SSCART-19 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ssCART-19
- 3
Studies by the year they started
3 studies that test it; most in 2025 (2)
| Year | Studies |
|---|---|
| 2024 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd (2) · Shanghai Tongji Hospital, Tongji University School of Medicine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test SSCART-19.
- Jan 2027Clinical Study of U01(ssCART-19) in Patients With B-Cell LymphomaPhase 1 · Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Studies
Open first, then newest update. How each study uses SSCART-19 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Clinical Study of U01(ssCART-19) in Patients With B-Cell LymphomaRecruitingPhase 1Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdNCT07093073Written as ssCART-19
- Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell LymphomaRecruitingPhase 1/2Shanghai Tongji Hospital, Tongji University School of MedicineNCT06987916Written as ssCART-19
- Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)Not yet recruitingPhase 2Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdNCT06367114Written as ssCART-19